Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transformation of FL into DLBCL with a PMBL gene expression signature. | Blood Adv | 2023 | 36240289 | PubTator, text mining | PubMed |
| Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. | J Cancer Res Clin Oncol | 2023 | 36239794 | PubTator, text mining | PubMed |
| Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study. | ESC Heart Fail | 2023 | 36184749 | PubTator, text mining | PubMed |
| Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment. | Semin Immunopathol | 2023 | 36167831 | PubTator, text mining | PubMed |
| Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. | J Invest Dermatol | 2023 | 36163302 | PubTator, text mining | PubMed |
| GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells. | Cell Mol Gastroenterol Hepatol | 2023 | 36155259 | PubTator, text mining | PubMed |
| Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. | Genes Dis | 2023 | 36097543 | PubTator, text mining | PubMed |
| Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma. | Cancer Sci | 2023 | 36082628 | PubTator, text mining | PubMed |
| COL3A1: Potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing. | Cancer Med | 2023 | 36039012 | PubTator, text mining | PubMed |
| Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36002754 | PubTator, text mining | PubMed |
| The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. | Hepatology | 2023 | 35989535 | PubTator, text mining | PubMed |
| Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine. | Anal Bioanal Chem | 2023 | 35970970 | PubTator, text mining | PubMed |
| Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells. | Anticancer Drugs | 2023 | 35946515 | PubTator, text mining | PubMed |
| Clinical and molecular change induced by repeated low-dose visible light exposure in both light-skinned and dark-skinned individuals. | Photodermatol Photoimmunol Photomed | 2023 | 35861041 | PubTator, text mining | PubMed |
| In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program. | Haematologica | 2023 | 35734926 | PubTator, text mining | PubMed |
| Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas. | Cancer Med | 2023 | 35702880 | PubTator, text mining | PubMed |
| Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma. | J Oncol | 2022 | 37342680 | PubTator, text mining | PubMed |
| Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients. | Front Immunol | 2022 | 36741391 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome. | Front Immunol | 2022 | 36741388 | PubTator, text mining | PubMed |
| Identification and classification of distinct surface markers of T regulatory cells. | Front Immunol | 2022 | 36741366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=40